MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-03-0111010
Deshpande Drugs Private Limited
Deshpande Drugs Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.62 Cr
▼ 4% YoY
Net profit · FY 2025
₹3.95 Lakh
Net margin 0.4%
EBITDA · FY 2025
₹15.78 Lakh
EBITDA margin 1.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2.52 Lakh
Issued & subscribed
Open charges
₹1.35 Cr
Satisfied ₹50 Lakh
Company age
11 yrs
Est. 2015
Directors on board
4
As per MCA filings
About Deshpande Drugs Private Limited
Data last updated:
Deshpande Drugs Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51103KA2015PTC083096. Its GSTIN is 29AAFCD4825J1ZE (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.52 Lakh. It is led by directors including Suma Kopparam Nagendra and Jahnavi Kashipathi Amarnath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 25 1st Floor 4th Main Road Inbetween 2nd & 3rd Cross Chamarajpet, Bangalore, Karnataka, India – 560018.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.62 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹3.95 Lakh (net margin 0.4%) and EBITDA of ₹15.78 Lakh (EBITDA margin 1.6%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years.
As per MCA filings, the company has open charges of ₹1.35 Cr and satisfied charges of ₹50 Lakh on record.
Deshpande Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0111010). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51103KA2015PTC083096
Registration Number 083096
Incorporation Date 05 October 2015
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-03-0111010
Key People
Suma Kopparam Nagendra Director Jahnavi Kashipathi Amarnath Director Kashipathi Manjunath Poornima Director Recognitions & Rankings of Deshpande Drugs
Contact details
Deshpande Drugs Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo. 25 1st Floor 4th Main Road Inbetween 2nd & 3rd Cross Chamarajpet, Bangalore, Karnataka, India – 560018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Deshpande Drugs Private Limited, buy the company report.
Comprehensive company report
Deshpande Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Deshpande Drugs is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Deshpande Drugs Private Limited, buy the company report.
Financials of Deshpande Drugs Private Limited
FY 2025 filings availableDeshpande Drugs Private Limited reported revenue of ₹9.62 Cr (down 4% YoY) for FY 2025.
Revenue · FY 2025
₹9.62 Cr ▼ 4%
Net profit · FY 2025
₹3.95 Lakh margin 0.4%
EBITDA · FY 2025
₹15.78 Lakh margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 2%
5 years · compounded
▼ 2%
Revenue has declined at a compounded annual rate (CAGR) of 1% over three years, including a 4% fall in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Deshpande Drugs Private Limited, buy the company report.
Board of directors of Deshpande Drugs Private Limited
Deshpande Drugs has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suma Kopparam Nagendra | Director | 09 Jun 2016 | 10 Years 4 Months | Current |
| Jahnavi Kashipathi Amarnath | Director | 09 Jun 2016 | 10 Years 4 Months | Current |
| Kashipathi Manjunath Poornima | Director | 09 Jun 2016 | 10 Years 4 Months | Current |
| Satish Mylaraiah Harogatta Also directs: Mind Connect Services Private Limited | Additional Director | 06 Jan 2026 | 0 Years 10 Months | Current |
Auditor
Deshpande Drugs Private Limited is audited by S ANANTH & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S ANANTH & CO | FY 2021 | 011772S |
Shareholding
The shareholding of Deshpande Drugs Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Deshpande Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.35 Cr
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Feb 2019 | 100253944 | Others | ₹1.35 Cr | Open | |
| 23 Aug 2017 | 100151790 | Others | ₹50 Lakh | Satisfied |
To see the full charge records of Deshpande Drugs Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Deshpande Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Deshpande Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Deshpande Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCD4825J1ZE | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Deshpande Drugs Private Limited, buy the company report.
Recent activity
Deshpande Drugs Private Limited has 7 board changes on record since 2016: 4 appointments and 3 cessations. The latest: Satish Mylaraiah Harogatta was appointed as Additional Director on 06 Jan 2026.
Appointed
Satish Mylaraiah Harogatta was appointed as Additional Director.
AGM
Deshpande Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Deshpande Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Shruthi Kumar Krishna ceased to be Director.
Charges
A charge registered on 23 Aug 2017 via Charge ID 100151790 with Others was fully satisfied on 10 May 2019.
Charges
A charge with Others amounted to Rs. 135.00 Lakh with Charge ID 100253944 was registered on 22 Feb 2019.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100151790 was registered on 23 Aug 2017.
Ceased
Deshpande Ahobalarao Gundurao ceased to be Director.
Ceased
Shobha Kiran Burli Gundu Rao ceased to be Director.
Appointed
Jahnavi Kashipathi Amarnath was appointed as Director.
Appointed
Kashipathi Manjunath Poornima was appointed as Director.
Appointed
Suma Kopparam Nagendra was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Deshpande Drugs is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 October 2015 (11+ years old) and is registered under CIN U51103KA2015PTC083096.
Deshpande Drugs has 4 current directors:
- Suma Kopparam Nagendra - Director
- Jahnavi Kashipathi Amarnath - Director
- Kashipathi Manjunath Poornima - Director
- Satish Mylaraiah Harogatta - Additional Director
The latest financial statements of Deshpande Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Deshpande Drugs is 29AAFCD4825J1ZE, registered in Karnataka.
The CIN (Corporate Identification Number) of Deshpande Drugs is U51103KA2015PTC083096. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deshpande Drugs was incorporated on 05 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
Satish Mylaraiah Harogatta was appointed as Additional Director on 06 Jan 2026. Shruthi Kumar Krishna ceased to be Director on 07 Feb 2022. Deshpande Ahobalarao Gundurao ceased to be Director on 14 Feb 2017. Deshpande Drugs has 7 board changes on record in total.
Yes, Deshpande Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0111010).
The registered office of Deshpande Drugs is at No. 25 1st Floor 4th Main Road Inbetween 2nd & 3rd Cross Chamarajpet, Bangalore, Karnataka, India – 560018.
Deshpande Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages